MT2014-05: A Phase I, First in Human Open Label Study to Evaluate the Safety and Tolerability of TRX103cell infusion in subjects with hematological malignancies undergoing HLA-mismatched related orunrelated hematopoietic stem cell transplantation (HSCT

Project: Research project

Project Details

Description

MT2014-05: A Phase I, First in Human Open Label Study to Evaluate the Safety and Tolerability of TRX103 cell infusion in subjects with hematological malignancies undergoing HLA-mismatched related or unrelated hematopoietic stem cell transplantation (HSCT
StatusActive
Effective start/end date4/30/241/31/34

Funding

  • TR1X, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.